论文部分内容阅读
目的:了解我院治疗糖尿病药的使用情况与趋势。方法:对我院2006-2008年治疗糖尿病药用量、销售金额、用药频度等进行回顾分析。结果:治疗糖尿病药销售金额逐年上升。3年中胰岛素销售金额占治疗糖尿病药总销售金额的41.49%,居第一位。胰岛素销售金额及DDDs呈逐年上升趋势,其中甘精胰岛素增幅最大。二甲双胍、α-葡萄糖苷酶抑制剂用药频度逐年增加。销售金额前10位的以进口或合资品种为主。达美康、二甲双胍和诺和灵50R,30R的DDDs连续3年居领先。结论:治疗糖尿病药需求量逐年增大。我院治疗糖尿病药的使用较合理,用药趋势变化与指南相符。
Objective: To understand the use of diabetes drugs in our hospital and the trend. Methods: The hospital from 2006 to 2008 treatment of diabetes medicine amount, sales amount, frequency of medication for retrospective analysis. Results: Sales of Diabetes drugs increased year by year. 3 years of insulin sales accounted for 41.49% of total sales of diabetes drugs, ranking first. Insulin sales and DDDs showed an upward trend year by year, of which insulin glargine increased the most. Metformin, α-glucosidase inhibitor medication frequency increased year by year. Sales of the top 10 to the main types of imports or joint ventures. Deltametholate, metformin and norcophenol 50R, 30R DDDs lead for three consecutive years. Conclusion: The demand for diabetes medicine is increasing year by year. Treatment of diabetes mellitus in our hospital is more rational use of medication trends consistent with the guidelines.